NorthWest Biotherapeutics Inc (NWBO)

[JRIII]

A 30 multiple is nothing for a company as expertly run as NWBO. When you factor in the potential of Direct and the fact that DCVax probably cures coronavirus, too, I think we are looking at (back of the napkin calculation here), say, $2 trillion in annual revenue. So a $60 trillion market cap is extremely conservative, imo. Even if we hit the 1.2 billion float we are still looking at $50,000-per-share - again extremely conservative. This, of course, assumes that everything plays out as I envision it. And when it does, I see Merck as our likely first acquisition, and then maybe Bristol. Once we add those two to our portfolio we'll be pretty close to cornering not just the cancer market, but the entire bio-pharmaceutical market. Again, this all very conservative based on everything we know about NWBO and its management.

TLD is coming - soon! Go Linda! Go Les! Go NWBO! Great posts everyone!